✦ LIBER ✦

159 Phase II study of OSI-774 given in combination with carboplatin in patients (pts) with recurrent epithelial ovarian cancer (EOC): NCIC ctg Ind.149

✍ Scribed by H. Hirte; A. Oza; P. Hoskins; S. Ellard; R. Grimshaw; J. Dubuc-Lissoir; I. Kerr; B. Fisher; L. Seymour

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of erlotinib (OSI-774)

✍ H. Hirte; A. Oza; K. Swenerton; S.L. Ellard; R. Grimshaw; B. Fisher; M. Tsao; L. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 180 KB

393 A phase II study of OSI-774 given in

✍ H. Hirte; K. Swenerton; A. Oza; S. Ellard; M. Plante; R. Grimshaw; M. Carey; L. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 123 KB

408 A phase II study of erlotinib in com

✍ E. Winquist; D. Soulieres; E. Chen; M. Tsao; M. Klein; G. Pond; J. Dancey; E. Ei 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 149 KB